Heck Capital Advisors, LLC Vericel Corp Transaction History
Heck Capital Advisors, LLC
- $1.47 Trillion
- Q4 2024
A detailed history of Heck Capital Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 150 shares of VCEL stock, worth $8,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$8,779% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
276Shares Held
48.4MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$472 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$224 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$142 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$139 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.76B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...